Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01605071 · ClinicalTrials.gov registry record · NA
Timing Estrogen After MenoPaUSe
A NA study of Insulin Resistance, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 53
- Enrollment target
- 1
- Study location
NCT01605071: Completed NA study of Insulin Resistance, sponsored by University of Colorado, Denver.
NCT01605071 is a NA study of Insulin Resistance that has completed, run by University of Colorado, Denver. The registered enrollment target is 53 participants, below the 245-participant average among 120 other Insulin Resistance trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01605071, a NA study of Insulin Resistance, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 53 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of the current study is to test whether the effect of estrogen on insulin metabolism depends on the timing of treatment relative to when a woman went through menopause. The investigators hypothesize that estrogen will improve insulin sensitivity in early postmenopausal women, but decrease insulin sensitivity in late postmenopausal women.
Primary Outcome
Estrogen mediated change in glucose disposal rate and time since menopause * Baseline GDR (no difference between groups) * E2 mediated change (significant difference between groups) randomized order of testing, cross-over design
Conditions Studied
Interventions
- DRUG Estradiol
Study Locations (1)
Colorado
- University of Colorado Denver - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2011-09 |
| Est. Completion | 2017-01 |
| Phase | NA |
What the finished NCT01605071 record still lists
NCT01605071 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 53 participants, a relatively small participant target, below the 245-participant average among 120 other Insulin Resistance trials with a reported enrollment target (78% lower).
The record links to 1 condition, with Insulin Resistance appearing as the primary indexed condition, and to 1 intervention - of which Estradiol is the first listed.
NCT01605071 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT01605071 about?
NCT01605071 is a clinical study titled "Timing Estrogen After MenoPaUSe". The aim of the current study is to test whether the effect of estrogen on insulin metabolism depends on the timing of treatment relative to when a woman went through menopause. The investigators hypothesize that estrogen will improve insulin sensitivity in early postmenopausal women, but decrease in...
What is the current status of trial NCT01605071?
This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2011-09. Estimated completion is 2017-01.
What conditions does trial NCT01605071 study?
This clinical trial studies the following conditions: Insulin Resistance.
What interventions are being tested in trial NCT01605071?
The interventions under investigation include: Estradiol (DRUG).
Who is sponsoring clinical trial NCT01605071?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01605071 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insulin Resistance
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01605071's enrollment target sits among peer trials
53 61st of 120 higher than 60 of 120 other Insulin Resistance trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Insulin Resistance trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling
RECRUITING · NA
-
Small Extracellular Vesicles and Insulin Action
RECRUITING · NA
-
Exercise Effects on Adipose Tissue Structure and Function
RECRUITING · NA
-
New Mechanisms of Obesity
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04177004 · 53 participants · Phase 1
Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant
- NCT04199741 · 53 participants · Phase 1
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
- NCT04835129 · 53 participants · Phase 2
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
- NCT04913805 · 53 participants · Phase 2
Matching Perfusion and Metabolic Activity in HFpEF
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia